Zydus Lifesciences gets USFDA nod for osteoporosis drug; stock hits 52-week high
The USFDA has allowed Zydus to manufacture and market Estradiol Transdermal System USP in the U.S; the drug will be produced at the group’s facility in Moraiya, Ahmedabad.
